XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.1

Contingent consideration

6 Months Ended

Dec. 31, 2023

Statement [line items]

Contingent consideration

Note 12. Contingent consideration

		Consolidated
		December 2023				June 2023
		$				$
Contingent consideration — Paxalisib			750,000				750,000
Contingent consideration — EVT801			808,931				—
			1,558,931				750,000

See also Note 15 setting out non-current contingent consideration.

X

- Definition

The disclosure of contingent consideration liabilities.

+ References

No definition available.

+ Details

Name:	kzia_DisclosureOfContingentConsiderationLiabilitiesExplanatory
Namespace Prefix:	kzia_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	kzia_StatementLineItems
Namespace Prefix:	kzia_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration